The Hype Check
AI hype is loud. AI adoption is silent. The Hype Check tracks named claims, published deployments, and publicly attributed outcome evidence where it is on record. Grounded in the independent [AIRS](/about/#airs) research program (Dr. Fabio Correa's doctoral work) and in 30 years of production-AI experience at enterprise scale. Start with the latest investigation, then use Providers and Buyers to pressure-test claims before your next funding call.
Latest
-
OpenAI Just Reframed Frontier AI Scores as a Setup Problem
OpenAI's new evaluation playbook says harness, budget, and validity checks can change results. That is a buyer warning, not just a safety note.
-
Cheaper Tokens Don't Close the Adoption-Value Gap
KPMG-Anthropic at workforce scale and Opus 4.8 at 61% lower token cost are real signals, not closure proof. The 88% vs ~5% gap lives at the outcome layer, not the input layer.
-
PwC's Second Announcement Had the Metrics, My First Verdict Missed Them
I collapsed two PwC announcements into one. A re-audit separates May 5 from May 14 and lands on an asymmetric verdict, compelling for the alliance, lukewarm for Advocate Health.
-
Starbucks Killed Automated Counting in 9 Months, and the Adoption-Value Gap Captured Itself
Starbucks rolled out NomadGo's computer-vision inventory tool across North America in September 2025, then retired it the week of May 18-22, 2026 and returned stores to manual counts. For the [adoption-value gap](/about/#airs), this is a rare named-buyer case where deployment and abandonment happened inside one observation window, making the gap visible without inference.
-
Two Weeks in Review (W21-W22): The Baseline for How We Read AI Adoption
This is the first two-weeks-in-review for The Hype Check and the baseline for our method. We score news against customer-facing levers, then separate signal from announcement noise.
-
What Andy Crowder Actually Bought: A Three-Lever Read of the PwC-Advocate Health Deal
The May 14 PwC-Advocate Health expansion through the CX-as-ROI three-lever filter. Capacity is the lever pulled; cost-to-serve and customer-felt functionality remain claimed but unevidenced.
-
What Buyers Actually Said: Two Weeks of Vendor Noise vs. Named Evidence
Four W21-W22 announcement clusters scored by named-buyer evidence depth. Three lukewarm, one skip. The contrast that shows where decision quality fails.
-
Welcome to The Hype Check
Phase 1 scaffold. The publication is live; the first real article ships in Phase 2 (June 2026).